BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
ZBTB7A
,
Apoptosis
,
Ischemia
,
Hypothalamus
,
Pharmacogenetics
,
Acetaminophen
,
rs2476601
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
factors IX
Summary
General Info
Curated Studies
Most Correlated Studies
OMIM - Hereditary disorder by system
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
L1000 CMAP - Non-small cell lung cancer HCC515 cells treated with ligand perturbagens
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
DNA methylation of GDF-9 and GHR genes as epigenetic regulator of milk production in Egyptian Zaraib…
High concentration of growth differentiation factor-9 (GDF-9) to the ram semen had a negative effect…
Preliminary results of blood growth differentiation factor-9 (GDF-9) measurement in cats: future asp…
F9 missense mutations impairing factor IX activation are associated with pleiotropic plasma phenotyp…
Serum GDF9 and BMP15 as potential markers of ovarian function in women with and without polycystic o…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Phase I/II Study of Monoclonal Factor IX Concentrate for Factor IX Deficiency
Factor IX as Adjunctive Therapy to Emicizumab (EMIX)
Natural History Study of Factor IX Treatment and Complications
A Study to Compare the Pharmacokinetics and Safety of Replenine®-VF, Replenine® or Other Factor IX i…
Post Marketing Study in Haemophilia B Patients Using Nonafact® (Human Coagulation Factor IX)
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ